X

Stay Connected

Sign Up for Updates

network1.png

PPA strives to improve patient health, advance medical innovation and fuel economic growth.

LEARN MORE
network1.png

The PhRMA Foundation supports the research and career endeavors of scientists in drug discovery and development.

LEARN MORE
network1.png

Access Better Coverage educates consumers about the ABCs of health coverage and access to medicines.

LEARN MORE
network1.png

We Work For Health aims to increase awareness by uniting workers throughout the industry.

LEARN MORE
network1.png

Patent protection should always be considered by an inventor during the initial stages of their invention.

LEARN MORE
logo_white_MyOldMeds-New-1.png

Working to spread awareness and education about the importance of secure drug disposal.

LEARN MORE
LTAC_NEW21.png

Many Americans are struggling to afford their medicines and have important questions about their medicine costs. Let's Talk About Cost addresses these questions.

LEARN MORE
logo_white_LTAM.png

There are a lot of conversations in Washington about how to change Medicare Part D, but they aren't always focused on what seniors care about most: affordability and predictability.

LEARN MORE
 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Priscilla VanderVeer

Priscilla VanderVeer is Vice President, Public Affairs, and leads the development, execution and management of public affairs and communications strategies and activities for PhRMA’s key state, federal and international advocacy priorities. She has more than two decades of experience communicating important health care issues to a wide variety of audiences, including medical, health and patient advocates, policymakers, opinion-leaders and the public. She lives in Annapolis, Maryland with her husband, Ken and their two dogs: Bea Arthur, a tiny 5 lb. Maltese and Henry, a slightly larger-than-average Yorkshire Terrier.

Recent Posts

Insurer and PBM tactics are shifting higher costs to patients with chronic and complex conditions

By Priscilla VanderVeer  |    March 2, 2023
Health plans are increasingly using deductibles and coinsurance to shift more of the cost of care to chronically ill patients taking brand medicines. As data from IQVIA show, this alarming trend is...   Read More

Rejecting ICER’s bad advice

By Priscilla VanderVeer  |    September 9, 2022
America leads the world in biomedical innovation today because our system rewards investment in research and discovery of new treatments. Now, with the passage of the Inflation Reduction Act, Dr....   Read More

Three things you should know about recent health care polling

By Priscilla VanderVeer  |    October 23, 2020
Pollsters have been busy this year tracking public sentiment around the top issues of concern for voters. Recent public polling shows that voters priorities have shifted dramatically over the course...   Read More

Trump administration must defend and protect U.S. innovation

By Priscilla VanderVeer  |    February 6, 2020
PhRMA recently submitted comments to the Office of the United States Trade Representative (USTR)’s Special 301 Report, calling on the Trump administration to defend American biopharmaceutical...   Read More

New Let’s Talk About Cost TV ad asks: Why aren’t patients sharing in savings at the pharmacy counter?

By Priscilla VanderVeer  |    July 9, 2019
For the last two years, our Let’s Talk About Cost campaign has sought to answer questions people have about their medicine costs and advance a dialogue on how we can make medicines more affordable...   Read More

Combatting Opioid Abuse: Joint Partnership with the Rx Abuse Leadership Initiative and The National Sheriffs’ Association

By Priscilla VanderVeer  |    February 12, 2019
The National Sheriffs’ Association (NSA) recently partnered with the Rx Abuse Leadership Initiative (RALI), a dynamic alliance of organizations dedicated to finding solutions to the opioid crisis...   Read More

New research shows increasing medication-assisted treatment rates could prevent 6.1 million overdoses and save over 800,000 lives

By Priscilla VanderVeer  |    December 17, 2018
New research released this week highlights the barriers that patients face in accessing medication-assisted treatment (MAT) for opioid use disorder (OUD) and the personal, health and societal...   Read More

Researchers bring focus on science and medicine to California’s capital city

By Priscilla VanderVeer  |    May 29, 2018
Health care issues are often so highly politicized that it’s easy to lose sight of the people behind the scenes, especially the millions of medical professionals that wake up each morning with a...   Read More

SB 17 doesn’t address pressing prescription drug transparency issues for CA voters

By Priscilla VanderVeer  |    August 30, 2017
California’s SB 17 is one of a number of bills relating to prescription drug transparency around prescription medicine costs that are winding their way through U.S. statehouses.   Read More

17 years (and more) of medical discoveries

By Priscilla VanderVeer  |    March 24, 2017
Someone asked me recently if donated kidneys last forever. It’s been 17 years and a few days since I received one, which has lasted 17 years longer than I thought it would. That may not be forever,...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates

Trending Posts

Most Popular Posts

Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review
"1. Information Collection."